These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 21958494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.
    Hill LF, Turner MA, Lutsar I, Heath PT, Hardy P, Linsell L, Jacqz-Aigrain E, Roilides E, Sharland M, NeoVanc Consortium.
    Trials; 2020 Apr 15; 21(1):329. PubMed ID: 32293527
    [Abstract] [Full Text] [Related]

  • 4. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
    Hill LF, Clements MN, Turner MA, Donà D, Lutsar I, Jacqz-Aigrain E, Heath PT, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja ML, Mahaveer A, Metsvaht T, Mitsiakos G, Papaevangelou V, Sarafidis K, Walker AS, Sharland M, NeoVanc Consortium.
    Lancet Child Adolesc Health; 2022 Jan 15; 6(1):49-59. PubMed ID: 34843669
    [Abstract] [Full Text] [Related]

  • 5. Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial.
    Shabaan AE, Nour I, Elsayed Eldegla H, Nasef N, Shouman B, Abdel-Hady H.
    Pediatr Infect Dis J; 2017 Apr 15; 36(4):358-363. PubMed ID: 27918382
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.
    Clin Ther; 2008 May 15; 30(5):868-83. PubMed ID: 18555934
    [Abstract] [Full Text] [Related]

  • 9. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
    Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, Antoniadou A, Carmeli Y, Nutman A, Levi I, Adler A, Durante-Mangoni E, Andini R, Cavezza G, Mouton JW, Wijma RA, Theuretzbacher U, Friberg LE, Kristoffersson AN, Zusman O, Koppel F, Dishon Benattar Y, Altunin S, Paul M, AIDA consortium.
    BMJ Open; 2016 Apr 20; 6(4):e009956. PubMed ID: 27098822
    [Abstract] [Full Text] [Related]

  • 10. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J, Brett SJ, De Waele JJ, Cotta MO, Davis JS, Finfer S, Glass P, Knowles S, McGuinness S, Myburgh J, Paterson DL, Peake S, Rajbhandari D, Rhodes A, Roberts JA, Shirwadkar C, Starr T, Taylor C, Billot L, Dulhunty JM.
    Crit Care Resusc; 2019 Mar 20; 21(1):63-68. PubMed ID: 30857514
    [Abstract] [Full Text] [Related]

  • 11. Ten- vs. 14-day antibiotic therapy for culture-positive neonatal sepsis.
    Islam K, Khatun N, Das K, Paul S, Ghosh T, Nayek K.
    J Trop Pediatr; 2023 Oct 05; 69(6):. PubMed ID: 37986651
    [Abstract] [Full Text] [Related]

  • 12. Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.
    Germovsek E, Lutsar I, Kipper K, Karlsson MO, Planche T, Chazallon C, Meyer L, Trafojer UMT, Metsvaht T, Fournier I, Sharland M, Heath P, Standing JF, NeoMero Consortium.
    J Antimicrob Chemother; 2018 Jul 01; 73(7):1908-1916. PubMed ID: 29684147
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.
    Rosso-Fernández C, Sojo-Dorado J, Barriga A, Lavín-Alconero L, Palacios Z, López-Hernández I, Merino V, Camean M, Pascual A, Rodríguez-Baño J, FOREST Study Group.
    BMJ Open; 2015 Mar 31; 5(3):e007363. PubMed ID: 25829373
    [Abstract] [Full Text] [Related]

  • 15. Neonatal bloodstream infections in a Ghanaian Tertiary Hospital: Are the current antibiotic recommendations adequate?
    Labi AK, Obeng-Nkrumah N, Bjerrum S, Enweronu-Laryea C, Newman MJ.
    BMC Infect Dis; 2016 Oct 24; 16(1):598. PubMed ID: 27776490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
    Novelli A, Adembri C, Livi P, Fallani S, Mazzei T, De Gaudio AR.
    Clin Pharmacokinet; 2005 Oct 24; 44(5):539-49. PubMed ID: 15871639
    [Abstract] [Full Text] [Related]

  • 18. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.
    Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.
    Trials; 2015 Jan 27; 16():24. PubMed ID: 25623485
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of meropenem in the treatment of serious infections in children: review of the current literature.
    Arrieta A.
    Clin Infect Dis; 1997 Feb 27; 24 Suppl 2():S207-12. PubMed ID: 9126695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.